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Background: The current study was to investigate the blood glucose changes in ultra-acute phase in patients with
ST-elevation myocardial infarction (STEMI) and its associations with patient outcome.
Methods: This study was a retrospective population-based observational study utilizing prospectively collected
registry data complemented with laboratory data. All adult patients with STEMI treated by emergency medical
services (EMS) in the city of Helsinki from January 2006 to December 2010 were included in the study. Both
prehospital and hospital admission glucose values were available from 152 (32%) of all STEMI patients (n = 469).
Results: Change in blood glucose from prehospital phase to emergency department admission was significantly
higher in non-survivors within 30 days compared to survivors (+1.2 ± 5.1 vs. -0.3 ± 2.4 mmol/l [mean ± SD], P = 0.03).
Furthermore, the 3-year survival rate was significantly lower in patients with an evident (≥2 mmol/l) rise in blood
glucose (P = 0.02). In patients with impaired left ventricle function (best ejection fraction < 40%), blood glucose
increased more compared to patients without it (1.2 ± 2.9 vs. 0.4 ± 2.7 mmol/l, P = 0.01). Increase in glucose was
correlated with peak myocardial creatinine kinase (r = 0.17, P = 0.04) as a marker of increased size of infarct, but not
with glycosylated haemoglobin A1C as a marker of chronic hyperglycaemia (r = −0.12, P = 0.27).
Conclusions: In patients with STEMI, ultra-acute hyperglycaemia during prehospital phase is associated with
increased mortality, impaired cardiac function and increased size of infarct.
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Hyperglycaemia characterizes up to 50% of patients
admitted with ST-elevation myocardial infarct (STEMI).
Of those, 20-25% have previously diagnosed diabetes [1].
The non-diabetic patients may have stress-induced
hyperglycaemia due to increased levels of insulin counter-
regulating mediators such as proinflammatory cytokines,
epinephrine, cortisol and tumour necrosis factor -alpha
[2]. On the other hand of hyperglycaemic patients without
previous diabetes at the time of STEMI, up to 40% actu-
ally were found having impaired glucose intolerance and* Correspondence: hanna.vihonen@hus.fi
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Hyperglycaemia at admission in STEMI patients, regard-
less of having diabetes or not, is an independent predictor
of in-hospital and long-term adverse outcomes like heart
failure, cardiogenic shock and death [4-6]. For every
1 mmol/l increase in blood glucose level, there is a 4%
increase in mortality in non-diabetic subjects and 5%
increase in diabetic subjects [2]. Glucose levels of STEMI
patients before arriving to hospital have not been
described.
Whether treatment of hyperglycaemia improves outcome
has not yet been definitely proved. The interventions to
modify glucose metabolism have been initiated in most
studies relatively late. For example, in the DIGAMI-II
treatment was started 13 hours after first symptoms ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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was not achieved [7]. Recently, early management of
dysglycaemia in acute myocardial ischemia has been
studied. Selker et al. have shown prehospital glucose-
insulin-potassium to decrease hospital mortality and
cardiac arrest incidence of patients with acute coronary
syndrome [8]. We have previously demonstrated that
hyperglycaemia of stroke patients can be effectively
treated in the prehospital phase by paramedics [9]. We
also have demonstrated in patients resuscitated from
out-of-hospital ventricular fibrillation that early hyper-
glycaemic response develops during prehospital phase
to patients with poor prognosis [10].
As ultra-acute hyperglycaemia is associated with poor
prognosis in other conditions involving pathophysiology
of ischemia and reperfusion and as being a relatively easily
modifiable factor, we aimed to describe the blood glucose
changes in prehospital phase in patients with STEMI
and association of these glucose changes with outcome
of these patients.
Methods
Study design
This study was a retrospective population-based observa-
tional study utilizing prospectively collected registry data
complemented with laboratory data. The study protocol
was approved by Helsinki University Hospital institutional
review board. According to local legislation, patient con-
sent was not required as only patient records and registry
data were used.
Patients
We included all adult (over 18 years) patients with STEMI
treated by emergency medical services (EMS) in the city
of Helsinki (population of approximately 568 000) from
January 1st 2006 to December 31st 2010. Only patients
who were confirmed to have STEMI in the hospital were
included. We excluded patients with missing prehospital
and/or hospital admission glucose values.
Treatment
In the city of Helsinki, EMS transports all the STEMI
patients to the single university teaching hospital. Early
presenters (<3 h from pain-onset) without cardiogenic
shock or significant heart failure are primarily treated
with prehospital fibrinolysis (tenecteplase) and all others
with primary-PCI. All patients were vigorously evaluated
for fibrinolysis-failure and early angiography is actively
performed. Criteria for successful fibrinolysis are 50%
resolution of ST-elevation and patient being painless and
stabile in a time interval of 60–90 minutes. Rescue-PCI
rate is 40%. Patients with successful fibrinolysis undergo
angiography within 24 hours.Setting and data sources
The Helsinki EMS STEMI registry is a prospectively col-
lected and includes all patients treated by EMS for
STEMI. Emergency physician or medical supervisor is
responsible of fulfilling the data into a structured data
collection form after each case. Designated emergency
physician verifies data based on EMS patient reports and
hospital patient records.
Blood glucose was measured by EMS providers using the
Optimum Xceed glucometer and MediSense Optimum
electrodes (Abbott Laboratories, Alameda, CA). In these
electrodes, the measurement is based on glucose dehydro-
genase reaction and the glucometer is plasma calibrated.
Prehospital blood glucose values were measured by ambu-
lance personnel before arrival to hospital. Blood glucose
measurement in the patients with chest pain is not
mandatory in the standard operating procedure and
thus depends on the consideration by the provider. Ad-
mission glucose values were included if taken within
24 hours of admission to hospital. Admission glucose
was measured in central laboratory using hexokinase
method in autoanalyser (Roche Diagnostics Hitachi 917,
Hitachi Ltd., Tokyo, Japan). Prehospital glucose values were
collected from the EMS patient reports. Admission glucose
values and glycosylated haemoglobin A1c (HbA1c, closest
value measured within one year of STEMI) values were
obtained from electronic laboratory database. Cardiac in-
farct marker myocardial creatininekinase (CK-MBm) was
obtained from electronic laboratory database. The left ven-
tricle ejection fraction was measured by a cardiologist using
an echocardiography and four-chamber planimetry. Data
of co-morbidities of patients (coronary syndrome, hyper-
tension, diabetes) were obtained from STEMI registry. All
other data were collected from hospital electronic patient
records. Patients were followed up to three years to assess
mortality using national population register data.
Analysis
The main outcome was 30-day survival and secondary
outcomes impaired function (left ventricle ejection frac-
tion <40%), ST-resolution, major bleeding and heart
failure. Change in blood glucose during prehospital phase
to hospital admission was compared between outcome
groups. Correlations of change in glucose with HbA1c and
CK-MBm were calculated. Long-term survival up to three
years was compared with subgroup with evident, over
2 mmol/l, ultra-acute rise in blood glucose. This cut-off
value was chosen because of inaccuracy of glucometers
might cause erroneously smaller rise in glucose compari-
sons. Additionally, we have previously shown it is possible
to modify blood glucose level equivalently during prehos-
pital phase [9].
Categorical data was analysed using either Fisher’s
exact (two groups) test or chi-square test (more than
Table 1 Available blood glucose values in prehospital
and admission phase of all STEMI patients treated during
the study period (n = 469)
Admission glucose
measurement available
Prehospital glucose
measurement available
Yes No
Yes 152 (32%) 6 (1%)
No 287 (62%) 24 (5%)
Patients with both prehospital and admission values available were included
in the study.
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mean ± standard deviation (SD) and skewed variables
as median and inter-quartile range (IQR). Spearman’s
correlation was calculated for change in blood glucose
and other continuing variables. Long-term survival was
analysed using Log-rank (Mantel-Cox) test. All statistical
analyses were carried out using GraphPad Prism 5.0 for
Mac OS X (GraphPad Software, San Diego, CA).
Results
During the study period, the Helsinki EMS treated total
of 469 patients with STEMI. Both prehospital and admis-
sion glucose values were available on one third of patients
who were consequently included in the study (Table 1).
Comparison of included and excluded patients is pre-
sented in Table 2, showing higher prevalence of diabetes
and anterior STEMI within included patients. There was
no difference in hemodynamic values between includedTable 2 Characteristics of patients with both prehospital and
patients) and patients with missing glucose values (excluded
All N
Age (years), median, IQR 62, 5
Sex, male (%) 336
Hypertension, % 182
Coronary artery disease, % 101
Diabetes, % 63
Weight (kg), median, IQR 75, 6
Admission glucose (mmol/l), median, IQR 7.8, 6
Localization of infarct, anterior (%) 235
Glycosylated haemoglobin A1C (%)*, median, IQR/Glycosylated
haemoglobin A1c (mmol/l), median IQR
5.9, 5.6-6.4
Systolic blood pressure (mmHg), mean ± SD 142
Pulse rate (beats per minute), mean ± SD 76 ±
Reperfusion strategy
Thrombolysis 307
Primary PCI 124
No reperfusion therapy 38
IQR, interquartile range; SD, standard deviation; PCI, percutaneous coronary interve
*Available in 89 and 144 cases of included and excluded patients, respectively.and excluded patient groups. Median interval from onset
of symptom to measurement of prehospital blood glucose
was 65 (IQR 41 to 130) minutes, and to measurement of
blood glucose after admission 170 (IQR 125 to 270)
minutes.
Overall, no significant difference was observed between
prehospital and admission glucose values (8.8 ± 3.3 mmol/l
and 8.7 ± 3.4 mmol/l, respectively, P = 0.50). Change in glu-
cose during prehospital phase in all patients was −0.3 ±
2.4 mmol/l. This change did not differ between 38 diabetic
patients and 114 non-diabetic patients (0.2 ± 3.2 mmol/l
and −0.3 ± 2.7 mmol/l, respectively, P = 0.37). Change
during prehospital phase was not correlated with HbA1C
(r = −0.12, P = 0.27) or dose of intravenous metoprolol
(r = 0.12, P = 0.14). Distributions of prehospital and admis-
sion glucose values, as well as change of blood glucose,
are shown in Figure 1.
Seventeen patients died within 30 days after admission.
Increasing ultra-acute change during prehospital phase
was significantly associated with 30-day mortality and
impaired left ventricle ejection fraction (Table 3). Fur-
thermore, change in glucose from prehospital to admis-
sion values was correlated with peak CK-MBm (r = 0.17,
P = 0.04).
Three-year survival was significantly lower in patients
with evident, over 2 mmol/l, increase in blood glucose
from prehospital phase to admission with a hazard ratio
of 3.78 (95% CI 1.30 to 11.7, P = 0.02). The survival
curves of these groups are presented in Figure 2.hospital admission glucose values available (included
patients)
= 469 Included patients
N = 152
Excluded patients
N = 317
P value
5-72 63, 54-73 61, 55-72 0.41
(72) 106 (70) 230 (73) 0.58
(39) 66 (43) 116 (37) 0.16
(22) 37 (24) 64 (20) 0.15
(13) 38 (25) 25 (7.9) <0.0001
0-86 80, 70-90 80, 70-90 0.75
.6-9.2 7.8, 6.4-9.8 7.7, 6.7-9.1 0.79
(50) 71 (47) 164 (52) 0.03
/41, 38-46 6.0, 5.7-6.6/42, 39-49 5.8, 5.5-6.3/40, 37-45 0.02/0.02
± 34 141 ± 33 143 ± 34 0.72
22 75 ± 20 77 ± 22 0.34
(65) 110 (72) 197 (62) 0.08
(26) 31 (20) 93 (29)
(8.1) 11 (7.2) 27 (8.5)
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Figure 1 Distribution of blood glucose values in prehospital (panel A), admission (panel B) and ultra-acute change of prehospital and
admission (panel C). Every dot represents a single patient.
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This is the first study to demonstrate an association
between ultra-acute increase of blood glucose during
prehospital phase and mortality in STEMI patients. Pa-
tients with increasing blood glucose had higher short-
term mortality. Interestingly, this outcome difference
was remained in three-year long-term survival analysis.
Early hyperglycaemic response seems to develop during
prehospital phase and is more pronounced in patients with
poor outcome. An ultra-acute increase in blood glucose
was associated with decreased cardiac function and increase
in marker of myocardial ischemia.
Previously it has been shown that hyperglycaemia at
admission is associated with poor short-term outcome
whereas chronic hyperglycaemia predicts long-term
outcome in the patients with AMI [11]. Diabetes is well-
known risk factor for cardiovascular events. Acute hyper-
glycaemia may be an independent factor that potentially
reflects more severe condition of the patient or alternativelyhas harmful effect per se, and thus is associated with higher
mortality to AMI. In the current study, ultra-acute blood
glucose change during prehospital phase was not associated
with diabetes or level of HbA1C, as an indicator of chronic
hyperglycaemia. This implies that these are two distinct
phenomena. Earlier studies on acute hyperglycaemia have
focused to single blood glucose at admission. The current
study implies that ultra-acute change may have a significant
role as well, even to long-term survival.
There are many potential mechanisms linking ultra-
acute hyperglycaemia to higher mortality and morbidity
in acute STEMI. Stress-induced acute hyperglycaemia
is caused by catecholamines, growth hormone, cortisol
and cytokines. Acute increase in those counter regula-
tory hormones lead to excessive increase in hepatic
glucose production and insulin resistance resulting in
hyperglycaemia. Insulin resistance causes excessive free
fatty acid production, which aggravates inflammation and
hence worsens endothelial dysfunction together with
Table 3 Association of outcome and blood glucose trend
from prehospital phase to hospital admission
Number
of patients
Change in glucose
from prehospital to
admission (mmol/l)
P value
30 days survival 0.03
Yes 135 −0.3 ± 2.4
No 17 1.2 ± 5.1
Ejection fraction 0.01
≥40% 126 0.4 ± 2.7
<40% 26 1.2 ± 2.9
Resolution of ST elevation 0.92
Yes 104 −0.2 ± 2.5
No 48 −0.1 ± 3.5
Major bleeding 0.07
No 147 −0.2 ± 2.8
Yes 5 2.1 ± 2.7
Acute heart failure or
cardiogenic shock
0.54
No 120 −0.2 ± 2.6
Yes 32 0.1 ± 3.5
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hyperglycaemia is characterized by suppression of flow-
mediated vasodilatation. This is manifested as impaired
microcirculation despite successful reperfusion [13]. Hyper-
glycaemia is associated with adverse effects on platelet func-
tion, fibrinolysis, coagulation and ischemic preconditioningFigure 2 Survival curves of patients with and without ultra-acute oveof the heart. These directly damage the myocardium
[14,15]. In the current observational study, hypergly-
caemic response was associated with impaired myocardial
function and greater infarct size although the definite
mechanisms cannot be determined.
Whether glucose control using insulin is beneficial in
STEMI is so far controversial. Major studies have found
no outcome benefit of GIK infusion after STEMI [7,16].
However, GIK infusion does not lead rapid control of
hyperglycaemia which has not been well studied yet. GIK
has been preferred as insulin per se might have some
beneficial effects in STEMI despite of glucose levels [17].
The main limitation of this study is that only one third
of STEMI patients treated during the study period had
sufficient data for analysis. This may result in a selection
bias. In the study population diabetics and patients with
anterior STEMI were overly presented. Data of potential
previous heart failure was also absent. A retrospective
design of the study limited also the study, although data
collection was mainly based on prospectively collected
registry data. The blood glucose values in the two time
points were measured using different methods, which
may have some effect on the results.Conclusions
This study demonstrated that in patients with STEMI,
ultra-acute hyperglycaemic response developing during
prehospital phase is associated with decreased cardiac
function, increased size of infarct and increased 30-day
mortality. Furthermore, also long-term survival is lowerr 2 mmol/l increase in blood glucose during pre-hospital phase.
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glucose. These findings implicate need of further studies
to evaluate results of modulation of this ultra-acute
hyperglycaemia.
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